Gao et al. demonstrated that neuronal apoptosis in the damaged hippocampal region is associated with anxiety- and depression-like behaviors, and identified amyloid beta precursor protein-like 2 (APPL2) as a potential therapeutic target for depression and olfactory deficits (Gao et al., 2018). Here, APPL2 is linked to depressive symptom measurement.